Although we cannot conclude from our data that MRE11 is involved in the sensitization of breast cancer cells to 3-Epi+cisplatin in Pit-1 overexpressed cells, our findings are in line with those observed by Huang et al. Further studies are necessary to confirm this data. Here, MRE11 is linked to breast carcinoma.